116 related articles for article (PubMed ID: 20703010)
1. Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.
Ide S; Fujiwara S; Fujiwara M; Sora I; Ikeda K; Minami M; Uhl GR; Ishihara K
J Pharmacol Sci; 2010; 114(1):107-10. PubMed ID: 20703010
[TBL] [Abstract][Full Text] [Related]
2. Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice.
Ide S; Sora I; Ikeda K; Minami M; Uhl GR; Ishihara K
Neuropharmacology; 2010 Jan; 58(1):241-7. PubMed ID: 19596019
[TBL] [Abstract][Full Text] [Related]
3. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Dhir A; Kulkarni SK
Neurosci Lett; 2007 Jun; 420(3):204-8. PubMed ID: 17532136
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
5. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Bacq A; Balasse L; Biala G; Guiard B; Gardier AM; Schinkel A; Louis F; Vialou V; Martres MP; Chevarin C; Hamon M; Giros B; Gautron S
Mol Psychiatry; 2012 Sep; 17(9):926-39. PubMed ID: 21769100
[TBL] [Abstract][Full Text] [Related]
6. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
Singh P; Singh TG
Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
[TBL] [Abstract][Full Text] [Related]
7. Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Dhir A; Kulkarni SK
Neurosci Lett; 2008 Nov; 445(1):83-8. PubMed ID: 18778754
[TBL] [Abstract][Full Text] [Related]
8. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
Berrocoso E; Mico JA
Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417
[TBL] [Abstract][Full Text] [Related]
9. Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
Holliday SM; Benfield P
Drugs; 1995 Feb; 49(2):280-94. PubMed ID: 7729333
[TBL] [Abstract][Full Text] [Related]
10. The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior.
Alvarez Silva A; Fernández-Guasti A
Pharmacol Biochem Behav; 2019 Dec; 187():172817. PubMed ID: 31655085
[TBL] [Abstract][Full Text] [Related]
11. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
Dhir A; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):921-5. PubMed ID: 17379375
[TBL] [Abstract][Full Text] [Related]
12. Remission from depression : a review of venlafaxine clinical and economic evidence.
Han D; Wang EC
Pharmacoeconomics; 2005; 23(6):567-81. PubMed ID: 15960553
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway.
Thomas J; Khanam R; Vohora D
Neurochem Int; 2016 Oct; 99():103-109. PubMed ID: 27311540
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.
Redrobe JP; Bourin M; Colombel MC; Baker GB
Psychopharmacology (Berl); 1998 Jul; 138(1):1-8. PubMed ID: 9694520
[TBL] [Abstract][Full Text] [Related]
15. Active behaviours produced by antidepressants and opioids in the mouse tail suspension test.
Berrocoso E; Ikeda K; Sora I; Uhl GR; Sánchez-Blázquez P; Mico JA
Int J Neuropsychopharmacol; 2013 Feb; 16(1):151-62. PubMed ID: 22217458
[TBL] [Abstract][Full Text] [Related]
16. Rapid onset of action of venlafaxine.
Montgomery SA
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814
[TBL] [Abstract][Full Text] [Related]
17. Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice.
Berrocoso E; Rojas-Corrales MO; Micó JA
Neurosci Lett; 2004 Jun; 363(1):25-8. PubMed ID: 15157989
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of venlafaxine in comparison with other antidepressants.
Lecrubier Y
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():29-35. PubMed ID: 7622815
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
Mazeh D; Melamed Y; Elizur A
J Clin Psychopharmacol; 1999 Jun; 19(3):284-5. PubMed ID: 10350042
[No Abstract] [Full Text] [Related]
20. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Horst WD; Preskorn SH
J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
